Skip to main content

Health condition · Clinically reviewed

Optic neuritis, sudden vision loss and what it can mean for MS.

Unilateral vision loss with pain on eye movement is a recognisable pattern - and often the first sign of a wider neurological picture. Getting the right tests early matters.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against NICE, RCOphth and peer-reviewed sources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK practice including MOG and AQP4 antibody testing and MRI-based MS risk counselling.

Key facts

Optic neuritis at a glance.

The essentials, in plain English - what it is, why the cause matters, and how it’s worked up in the UK today.

  • What it is

    Inflammation of the optic nerve, causing subacute vision loss - often the first sign of an underlying demyelinating condition.

  • Most common cause

    In the UK, typical optic neuritis is most often the presenting feature of multiple sclerosis (MS).

  • Other causes

    NMOSD (usually more severe or bilateral) and MOGAD - both need antibody testing because management differs from MS.

  • Classic pattern

    Unilateral vision loss over hours to days, pain worse on eye movement, and reduced colour vision.

  • Key investigation

    MRI of the brain and orbits - assesses the optic nerve lesion and looks for demyelinating plaques suggestive of MS.

  • Outlook

    Most typical cases recover good vision over weeks to months, with or without steroid treatment.

Why this guide matters

The eye is often the first clue.

Optic neuritis is common, usually recoverable, and frequently the earliest visible sign of something bigger. The three points below shape everything else on this page.

  • The pattern is recognisable

    Unilateral vision loss with pain on eye movement is a distinctive enough pattern that urgent assessment should follow, not a wait-and-see approach.

  • MRI does more than confirm it

    The scan that diagnoses the optic nerve lesion is the same scan that estimates your individual risk of a future MS diagnosis.

  • The antibody result changes the plan

    AQP4 and MOG testing separates typical MS-associated cases from NMOSD and MOGAD - three conditions treated quite differently.

How the diagnosis is made

From first symptoms to a clear picture.

The steps a UK ophthalmologist or neurologist will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Urgent same-week assessment

    Subacute unilateral vision loss with eye-movement pain needs urgent ophthalmology or neurology review, not a routine wait.

  2. 02

    Assessing

    Pupil and colour vision testing

    A relative afferent pupillary defect and red desaturation are classic early clinical signs, checked at the bedside.

  3. 03

    Assessing

    Visual field assessment

    Formal perimetry maps the central or paracentral field defect that is typical of optic nerve involvement.

  4. 04

    Confirming

    MRI brain and orbits

    Confirms the optic nerve lesion and, crucially, looks for white-matter plaques that raise the likelihood of MS.

  5. 05

    Confirming

    AQP4 and MOG antibody testing

    Blood tests to exclude NMOSD and MOGAD - important because both are treated differently from typical MS-associated optic neuritis.

  6. 06

    Confirming

    OCT and visual evoked potentials

    Optical coherence tomography tracks retinal nerve fibre layer thinning; VEPs can confirm slowed optic nerve conduction.

  7. 07

    Clarifying

    Selective lumbar puncture

    Used in some cases to look for oligoclonal bands, supporting an MS diagnosis when the picture is uncertain.

Typical timeline: urgent assessment within days, MRI and blood results within one to two weeks.

Symptoms

What optic neuritis actually feels like.

The classic mix of unilateral vision loss, eye-movement pain and colour desaturation. And the features that mean it’s time to reconsider the diagnosis.

  • Unilateral vision loss

    Usually one eye, developing over hours to days - the hallmark presenting symptom.

  • Pain on eye movement

    A characteristic feature - aching or pulling pain that worsens when the eye moves, often preceding vision loss.

  • Reduced colour vision

    Colours, especially red, look washed out or desaturated compared with the unaffected eye.

  • Relative afferent pupillary defect

    The affected pupil constricts less to direct light than the healthy eye - a key clinical sign.

  • Central or paracentral field defect

    A blurred or blind patch in the centre of vision, mapped on formal visual field testing.

  • Blurred or dim vision

    Vision can range from mild blurring to significant loss, sometimes worsening over a few days.

  • Bilateral or severe presentation

    More typical of NMOSD than MS - a red flag prompting urgent antibody testing.

  • Red flag - painless or rapidly progressive loss

    Painless onset, lack of eye-movement pain, or very rapid deterioration should prompt reconsideration of the diagnosis.

Treatment

How optic neuritis is managed in the UK.

Urgent assessment first, steroids to speed recovery where appropriate, and a treatment path shaped by MRI findings and antibody results.

  • Urgent specialist referral

    Same-week ophthalmology or neurology assessment to confirm the diagnosis and start the right investigations.

  • High-dose IV corticosteroids

    Commonly used to speed visual recovery - though many typical cases reach a similar eventual visual outcome regardless.

  • MRI-based MS risk counselling

    The number and pattern of brain lesions on MRI predicts the chance of a future MS diagnosis, shaping the conversation about what comes next.

  • Disease-modifying therapy

    Considered when MRI findings suggest a high risk of MS conversion, started early with neurology input.

  • NMOSD-specific treatment

    If AQP4 antibodies are positive, acute and long-term management differs from MS - see our NMOSD guide.

  • MOGAD-specific treatment

    MOG antibody-positive disease also follows its own acute and maintenance pathway - see our MOGAD guide.

  • Specialist follow-up

    Ongoing neurology and ophthalmology review to monitor recovery, repeat MRI where indicated, and reassess MS risk over time.

  • Visual rehabilitation support

    For the minority with residual visual impairment, low-vision services and practical adaptations support daily function.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your ophthalmologist or neurologist knows your history and scan results and can tell you which parts apply to you. If in doubt, get seen urgently.

  • NICE. Multiple sclerosis in adults: management (NG220).

  • Royal College of Ophthalmologists (RCOphth). Optic neuritis clinical guidance.

  • Association of British Neurologists (ABN). Guidelines for NMOSD and MOGAD.

  • MAGNIMS/ECTRIMS. MRI criteria in the diagnosis of multiple sclerosis.

Red flags

When it isn’t a typical picture.

Most optic neuritis follows a predictable, recoverable course. These are the situations that call for closer or more urgent attention.

  • Bilateral simultaneous vision loss

    Uncommon in typical MS-associated optic neuritis and raises suspicion of NMOSD - needs urgent antibody testing.

  • Painless onset

    The absence of eye-movement pain should prompt reconsideration of the diagnosis and wider work-up.

  • Very severe or rapidly progressive loss

    Profound visual loss over hours, or continued worsening beyond two weeks, is atypical and needs urgent specialist review.

  • No recovery after steroids

    Failure to improve should trigger reassessment for NMOSD, MOGAD, or an alternative diagnosis altogether.

  • Systemic features

    Fever, rash, or other neurological symptoms alongside vision loss suggest a broader inflammatory or infectious process.

  • Older age at first presentation

    Optic neuritis presenting after 50 is less typical for MS and warrants a broader differential, including ischaemic causes.

  • Positive AQP4 antibodies

    Confirms NMOSD - a more aggressive condition requiring different acute treatment and long-term immunosuppression.

  • Positive MOG antibodies

    Confirms MOGAD - its own distinct relapse and treatment pattern, different from both MS and NMOSD.

  • Recurrent episodes

    Repeated attacks, especially bilateral or severe ones, increase the priority of antibody testing and long-term specialist planning.

Living with it

Recovery, follow-up and looking ahead.

Four things that matter most in the weeks and months after diagnosis - patience with recovery, staying on top of follow-up, looking after your wellbeing and knowing when to speak up.

A quiet reminder

A slow recovery is still a recovery.

Vision often keeps improving for months after the acute episode - don’t judge the outcome too early.

  1. 01 Recovery

    Expect gradual improvement

    Vision typically starts recovering within two to four weeks and continues improving for several months.

  2. 02 Monitoring

    Keep MRI and clinic appointments

    Follow-up scans and reviews track both visual recovery and any evolving risk of MS.

  3. 03 Wellbeing

    Ask about the emotional impact

    A new diagnosis, or the uncertainty around MS risk, can be unsettling - specialist nurses and support services can help.

  4. 04 Escalate

    Report any new symptoms promptly

    New neurological symptoms, or vision changes in the other eye, should be reported to your specialist team without delay.

Frequently asked

Everything we get asked about optic neuritis.

Quick answers on MS risk, MRI, antibody testing and steroid treatment.

  • What is optic neuritis?

    Inflammation of the optic nerve, the nerve that carries visual signals from the eye to the brain. It typically causes subacute vision loss in one eye, often with pain on eye movement, and is commonly the first presenting feature of multiple sclerosis.

  • Does optic neuritis mean I have multiple sclerosis?

    Not necessarily. Optic neuritis is often the first sign of MS, but it can also occur in isolation, after an infection, or as part of NMOSD or MOGAD. MRI findings help estimate your individual risk of going on to develop MS.

  • Why do I need an MRI?

    MRI of the brain and orbits confirms the optic nerve lesion and looks for other demyelinating plaques. The number and location of any additional lesions is the strongest predictor of future MS risk and guides whether disease-modifying therapy is considered.

  • What is the difference between MS, NMOSD and MOGAD optic neuritis?

    All three can cause optic neuritis, but NMOSD tends to be more severe or bilateral, and both NMOSD and MOGAD are confirmed with blood antibody tests (AQP4 and MOG). Management differs between the three, which is why antibody testing matters.

  • Do I need steroids?

    High-dose intravenous corticosteroids are commonly used to speed up visual recovery. In many typical cases the eventual visual outcome is similar with or without steroids, so the decision is made with your specialist based on severity and individual circumstances.

  • Will my vision fully recover?

    Most people with typical optic neuritis regain good vision over weeks to months, though subtle changes in colour vision or contrast sensitivity can persist. Recovery tends to be less complete in NMOSD, which is one reason accurate diagnosis matters.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.